Surprisingly, in both the tumour and spleen, the number of M1 macrophages (iNOS+) was remarkably increased while the number of M2 macrophages (CD206) was reduced in naphplatin-treated tumour-bearing mice in comparison to the control. Here, MRC1 is linked to neoplasm.